Physician

Alexandra Grammenos, DO

According to 2025 Medicare claims, Alexandra Grammenos, DO (NPI: 1477059590) practices dermatology in the Sebastian-Vero Beach-West Vero Corridor, FL market, with the plurality of this provider's patient population coming from Indian River, FL. This provider's primary affiliated billing organization is LEAVITT MEDICAL ASSOCIATES OF FLORIDA INC (NPI: 1528097284; TIN: 593549147) and primary practice location at 32960-6528. Grammenos is affiliated with the Rancho Health Management, LLC (ACO ID: D0015), participating under the REACH model.

Grammenos' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,112 traditional Medicare patients, billed 5,080 HCPCS/CPT codes, and received $268,867 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 928 prescription claims across 526 beneficiaries totaling $85,212 in drug costs, led by Clobetasol Propionate (Clobetasol Propionate). Open Payments data shows 22 records totaling $638. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $1,263 to $85,212. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	435	1,903	$96,735
2022	733	4,150	$209,403
2023	720	3,538	$153,056
2024	1,112	5,080	$268,867

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	27	40	$1,263
2020	36	54	$1,566
2021	179	312	$37,269
2022	474	934	$372,268
2023	301	562	$301,894
2024	526	928	$85,212

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17110	Destruction of skin growth, 1-14 growths	280	328	$80
11102	Biopsy of related skin growth, first growth	280	338	$67
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	609	807	$62
17000	Destruction of precancer skin growth, 1 growth	420	556	$39
17003	Destruction of precancer skin growth, 2-14 growths	299	1,743	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Clobetasol Propionate	Clobetasol Propionate	173	5,043	$5,784
Triamcinolone Acetonide	Triamcinolone Acetonide	139	4,639	$2,149
Ketoconazole	Ketoconazole	101	2,804	$1,530
Desonide	Desonide	21	508	$1,526
Mupirocin	Mupirocin	215	4,147	$1,479

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	22	$638	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alexandra Grammenos, DO?

Tedicare shows public-source Medicare data for Alexandra Grammenos, DO (NPI 1477059590), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alexandra Grammenos, DO have ACO affiliation data?

Alexandra Grammenos, DO is shown with ACO affiliation data for Rancho Health Management, LLC (REACH, ACO ID D0015).

What billing organization is linked to Alexandra Grammenos, DO?

Alexandra Grammenos, DO is linked to LEAVITT MEDICAL ASSOCIATES OF FLORIDA INC (billing NPI 1528097284) in the available physician profile data.

Does Alexandra Grammenos, DO have Open Payments data?

Alexandra Grammenos, DO has 22 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.